Dr Max Kates

Max Kates, MD is the Christian B Evenson Professor of Urology and Oncology at Johns Hopkins University School of Medicine, where he serves as Director of the Division of Urologic Oncology and Co-Director of the Greenberg Bladder Cancer Institute . A nationally recognized expert in bladder cancer, Dr. Kates combines a high-volume surgical practice with leadership of practice-changing clinical trials, including chairing the Phase 3 EA8212 BRIDGE trial which is one of the largest clinical trials ever performed in bladder cancer.

His translational research has advanced understanding of immune resistance in BCG-unresponsive disease, pioneered novel intravesical therapies, and explored antibody–drug conjugates and immunotherapy for bladder preservation. He has published widely with over 150 peer reviewed publications in leading urology and cancer journals and has received continuous funding, including an American Cancer Society Career Development Award.